| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Our laboratory recently developed a diagnostic test (ELISA) for human fascioliasis based on the detection of serum IgG4 antibodies reactive with Fasciola hepatica cathepsin L1 (CL1). In the present study, we have used recombinant CL1, generated by functional expression of the cDNA in Saccharomyces cerevisiae, in this immunodiagnostic test and compared its performance with native CL1. Sera obtained from 64 individuals living in Cutusuma village in the northern Altiplano of Bolivia, a region with a high prevalence of human fascioliasis, were analyzed by the IgG4-ELISA. A highly statistically significant correlation (r2 = 0.751, P < 0.001) was demonstrated between the absorbances obtained using the recombinant and native proteins. These assays showed that 38 (59%) of the individuals tested were seropositive for fascioliasis, whereas only 26 of them were coprologically positive for F. hepatica eggs. All seronegative patients were also coprologically negative. Serum from individuals infected with schistosomiasis mansoni, cysticercosis, hydatidosis, and Chagas disease did not contain antibodies reactive with the recombinant or native CL1. Therefore, recombinant CL1 shows excellent potential for the development of the first standardized assay for the sensitive and specific diagnosis of human fascioliasis. Finally, our data supports earlier reports on the high prevalence of human fascioliasis in the Bolivian Altiplano, which collectively suggest that the disease has been endemic there for more than a decade.
This article has been cited by other articles:
|
|
 |
|
  M. W. Robinson and J. P. Dalton Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases Phil Trans R Soc B, September 27, 2009; 364(1530): 2763 - 2776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Marcilla, J. E. De la Rubia, J. Sotillo, D. Bernal, C. Carmona, Z. Villavicencio, D. Acosta, J. Tort, F. J. Bornay, J. G. Esteban, et al. Leucine Aminopeptidase Is an Immunodominant Antigen of Fasciola hepatica Excretory and Secretory Products in Human Infections Clin. Vaccine Immunol., January 1, 2008; 15(1): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. ESPINOZA, V. MACO, L. MARCOS, S. SAEZ, V. NEYRA, A. TERASHIMA, F. SAMALVIDES, E. GOTUZZO, E. CHAVARRY, M. C. HUAMAN, et al. EVALUATION OF FAS2-ELISA FOR THE SEROLOGICAL DETECTION OF FASCIOLA HEPATICA INFECTION IN HUMANS Am J Trop Med Hyg, May 1, 2007; 76(5): 977 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wongkham, C. Tantrawatpan, P. M. Intapan, W. Maleewong, S. Wongkham, and K. Nakashima Evaluation of Immunoglobulin G Subclass Antibodies against Recombinant Fasciola gigantica Cathepsin L1 in an Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Human Fasciolosis Clin. Vaccine Immunol., October 1, 2005; 12(10): 1152 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. TANTRAWATPAN, W. MALEEWONG, C. WONGKHAM, S. WONGKHAM, P. M. INTAPAN, and K. NAKASHIMA SERODIAGNOSIS OF HUMAN FASCIOLIASIS BY A CYSTATIN CAPTURE ENZYME-LINKED IMMUNOSORBENT ASSAY WITH RECOMBINANT FASCIOLA GIGANTICA CATHEPSIN L ANTIGEN Am J Trop Med Hyg, January 1, 2005; 72(1): 82 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Carnevale, M. I. Rodriguez, G. Santillan, J. H. Labbe, M. G. Cabrera, E. J. Bellegarde, J. N. Velasquez, J. E. Trgovcic, and E. A. Guarnera Immunodiagnosis of Human Fascioliasis by an Enzyme-Linked Immunosorbent Assay (ELISA) and a Micro-ELISA Clin. Vaccine Immunol., January 1, 2001; 8(1): 174 - 177. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
